Inventor · disambiguated record
Seyoung Lim
Also filed as: LIM SEYOUNG
2 granted patents·7 pending applications·6 citations·filing 2016–2024
50Inventor score
Files withYUHAN CORP9
Top patents by PatentIndex Score
9 records- 0191US11136364B2Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2016·Granted Oct 5, 2021·6 cites·25 claims
- 0279US2025270269A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2024·Application pending·0 cites
- 0376US2024279296A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2023·Application pending·0 cites
- 0468US2022002367A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 0568US2022002368A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 0662US11142557B2Long-acting FGF21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2016·Granted Oct 12, 2021·0 cites·17 claims
- 0758US2024082354A1Composition for preventing or treating non-alcoholic fatty liver disease or non-alcoholic steatohepatitis comprising growth differentiation factor-15 variantYUHAN CORP·Filed 2023·Application pending·0 cites
- 0853US2024238380A1Composition for combination therapy comprising growth differentiation factor-15 variant and glucagon-like peptide-1 receptor agonistYUHAN CORP·Filed 2022·Application pending·0 cites
- 0949US2023002460A1Long-acting gdf15 fusion protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seyoung Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →